Click Here to
receive daily
reports of the
TOP PICKS
OR
your personal
stock choices

STOCKCHASE

What the experts are saying!
This site compiles comments that experts make about stocks while on public TV shows.

There are 4 registered members and 57 guests viewing the site. Follow us on Twitter Rss Top Picks FeedRss Daily Feed

VSM MedTech Ltd.
Symbol: VSM-T
Active: N
Sector: biotechnology/pharmaceutical
Notes:MIR? Surgeons can look inside the brain in a non-invasive manner.
Last Price: 0.050
Last Price Date: 2006-10-17 22:17:24
Globe 200 day average

Experts who have talked about VSM MedTech Ltd.

DON'T BUY0.090Robert FloydRecently entered into a financing agreement. Cash strapped. Existing shareholders tend to get totally diluted of their positions.2006-08-18
SELL0.070Robert McWhirterRanks near the bottom. Earnings have been shaved by 23%. Recent financing was very dilutive.2006-07-25
DON'T BUY0.475Robert McWhirterRanks in the bottom 1% of his database. Earnings estimates have been revised downwards 12% in the last 90 days.2006-05-04
DON'T BUY0.530Robert McWhirterIt is interesting technology. The company is suffering. Give it a pass. He has owned in the past. 2006-03-13
DON'T BUY0.700Robert McWhirterHas very good technology, but unfortunately it is still in the early stages of being rolled out to the medical community. In the bottom 15% of his database. Earnings estimates have been shaved by about 5% in the last 90 days and 20% in the last 60 days. Most recent quarter had a negative earnings surprise. Expected to lose $0.23 in ’06 and $0.15 in ’07.2005-12-08
PAST TOP PICK0.560Brendan Kyne(A Top Pick Nov 19/03. Down 83%.) Stock did very well for a whle, but the company was not able to make a viable business. Sold off a long time ago.2005-05-31
DON'T BUY0.600Peter HodsonA tough one because the company is struggling with a management team that is being paid too much. Not doing well from a sales point of view and one of their competitors is starting to give away products as a bundling package. 2005-04-07
VAGUE0.900David Taylor, MBA, CFAThe bane of his existence. Comes back to haunt him. Has not got this one right at all.2005-02-02
VAGUE1.040Scott MorrisonHave had a lot of trouble. Lost their CEO. Have to do more research with management before investing. Have some interesting technology. Starting to look interesting.2005-01-14
BUY0.940Peter HodsonLikes the company and their technology. Management team is improving operations, but they get paid way too much money. The question is; are they going to increase their sales base and ultimately sell the company or dwindle as a small cap. Under $1 there's not a whole lot of risk.2004-12-20
DON'T BUY0.670Robert McWhirterNot expected to earn any money. In the bottom 2% of the database. Year over year sales are down 43% and earnings down 71%.2004-12-09
DON'T BUY0.690Duncan StewartCFO is gone and they have laid off the COO. Have sold zero units of their new technology. Running out of cash.2004-11-12
BUY on WEAKNESS0.900Peter HodsonHave been looking at it. Been beaten up more than it should be. Entering tax-loss selling season, so it could drop further. Still believes in the technology. New management could make a difference.2004-11-04
WAIT1.460Peter HodsonShort term, it won't be good. Expect some tax loss selling in the last quarter. May take 3/4 years to get a big bang. Good product.2004-09-24
WAIT2.750Peter HodsonA pretty good " put away" stock. New management team is in place. Great technology. Will wait for a couple of more quarters before buying.2004-07-08
STRONG BUY3.090David Taylor, MBA, CFABullish on this stock. Have completely changed the management team. Expect there will be some announcements soon. Have a ton of cash.2004-06-22
WAIT2.980Ed HoHas a great product. Had some accounting issues. Expects they will succeed in the long term. Have to start showing sales. A " show me" company.2004-06-21
DON'T BUY2.700Robert McWhirterEarnings estimates have been chopped by 95% in the last three months. Earnings are expected to improve. Too expensive.2004-06-02
DON'T BUY2.470Andrew McCreathExpected to lose $.90 a share in the forward 12 months. Even if they have a turnaround, they will need more cash. Wait for a solid turnaround.2004-04-20
BUY2.940David Taylor, MBA, CFAIs averaging down. Great product. New management is spectacular, but a " wait and see" situation. Could be dead money.2004-04-06
DON'T BUY2.940Ian NakamotoWould still be a little leery of this company.2004-04-06
BUY on WEAKNESS2.500Peter HodsonHad a change in management which is starting to guide realistically. Would buy in the low $2's (preferably under $2) for a 2 year hold. To him2004-03-23
DON'T BUY2.900Peter HodsonNew CEO. Price is pretty expensive based on real revenues. Would consider at $2. Good product and good technology.2004-03-02
WATCH2.580Robert McWhirterPresident just resigned. A turnaround, but it ranks in the bottom 3% of the database. Earnings estimates have been chopped by 40% in the last 90 days. Overall sales down 60%. Needs more time.2004-02-27
VAGUE2.550Michael SmedleyThis is a company with large, high cost equipment. They only expect to sell 8/10 a year. If something goes wrong with a couple of sales it creates a lot of trouble.2004-02-25
DON'T BUY3.330David KramerNot a buyer at this price.2004-02-13
WATCH3.320Robert McWhirterRanks in the bottom 7% of the database. Guidance on sales has been downward. Earnings estimates have dropped 23%. New management should turn things around.2004-02-12
DON'T BUY3.650Peter HodsonManagement change was good. A very expensive stock. They are restating all the revenues. Great technology. Would like to see a couple of multiple orders rather than one at a time.2004-01-23
DON'T BUY3.600David BaskinHad some accounting difficulties. They live and die by every single sale. Very highly speculative. Good technology. If they get some stable revenue, the stock should be a good one.2004-01-22
WATCH3.780Robert McWhirterRanks in the bottom 4% of the database. New management. More conservative accounting practices. Sales growth is down. Very good technology. Expected it will be June/04 before you begin to see any traction.2004-01-15
PAST TOP PICK3.820David Taylor, MBA, CFA(A past top pick Nov 17/03. Up 14.6%.) Great new management team. They've cleaned up their accounting. Dropping because of one seller.2004-01-14
DON'T BUY4.160Benj GallanderRevenues dropped and they lost some contracts. Have a large debt load. Too expensive.2004-01-09
WATCH3.800Mike WeirWith the drop in the price, can't see a huge valuation risk. Bringing in a new CEO is good. The bigger risk is if there is a good market for their devices. Very speculative.2003-12-22
WAIT3.870Peter HodsonOver aggressive sales practices resulted in $150 million market cap reduction by the market. A new change in President and is now working its way back. Very expensive based on their new revenue recognition policy. Would be viable at the $2/2.50 range.2003-12-04
DON'T BUY4.500Ted MacklinAs a conservative investor, not his type of investment. Sloppy accounting practices give huge credibility issues. Change of CEO is probably good.2003-12-03
BUY3.930David BaskinHave a real technology. The stock dropped, because they had orders which were booked as revenue and which did not come through. Somewhat speculative because of dependency on sales.2003-11-26
PAST TOP PICK3.930Robert McWhirter(A top pick Oct 10/03. down 7.55/3.95%.) Lost a sale through a customer’s bad financing. Still likes.2003-11-21
TOP PICK3.750Brendan KyneBecause of a customers financing difficulty, took a big drop. They have been adding to their positions at the lower price. Their technology is infallible. Should be a very successful story.2003-11-19
TOP PICK3.140David Taylor, MBA, CFAGreat product with strong demand. Had to restate 2nd quarter results because of a deal falling through. Being oversold. Great price.2003-11-17
WAIT6.720Lou SchizasThe chart on this stock gives a little bit of concern. It looks like a double top. Tried to break through $7.80 twice. Wait for it to break through. Currently looking at developing an MRI hybrid for imaging of the brain in utro(?) foetuses.2003-10-24
TOP PICK7.550Robert McWhirterHave just made a deal with GE for distribution in China. 120% earnings growth.2003-10-10
BUY6.340Michael SmedleyA very exciting company. Prices dropped, so a good buying opportunity.2003-09-30
TOP PICK7.500Robert McWhirterHave a new product. Being recognized by insurance companies. Expects a 13% upside.2003-09-16
BUY7.340David Taylor, MBA, CFABuy for the long term. Very attractive valuation.2003-09-12
BUY6.800Peter HodsonHas a pretty high valuation right now, but has potential to grow into it. Demand for their product has great upside. Probable takeover down the road.2003-09-09
TOP PICK6.890Robert McWhirterA highly speculative stock. Has tripled in price. Just sold their seventh machine.2003-08-29
BUY6.720Kyle McKayHas just hit an all-time high. This price represents an excellent buying opportunity. Expect them to sell 12 or13 of their systems this year at $2 million each.2003-08-28
STRONG BUY6.570Brendan KyneReimbursements for the tests have doubled in the US.To be a takeover down the road.Looks very attractive.Should have explosive growth ahead of it.2003-08-26
PAST TOP PICK5.970Glenn Paradis, BA, CFA(Was the top pick on May 20/03.Up 256%.)Still likes.Sold half of their shares.Could drop to five dollars but will still keep.2003-08-13
BUY6.040Michael SmedleyLooks like a very strong situation.Getting some favorable announcements.A very competent company.2003-08-08
BUY4.430David Taylor, MBA, CFAOne of the best stories he's heard in a long time.Has done exceptionally well.Selling their product globally.Margins are over 50%.A buy and hold stock.2003-08-05
WEAK BUY3.960Robert McWhirterWell ranked in their Quant database model. The question is, can they deliver the earnings growth that is forcast. Their procedure has been approval for coverage ny insurance. Expensive.2003-07-31
BUY3.920Peter HodsonA great company. Has a little concern on the dramatic price rise. Great growth prospects as there is growing customer demand.2003-07-29
TOP PICK2.700Kyle McKayHas 85% market share of meg(?) machines. Will probably earn 6/7% per share this year.2003-07-03
TOP PICK1.640Glenn Paradis, BA, CFAImproving operationally. Sales are increasing by 100% from last year. Profitable.2003-05-20
DON'T BUY2.000Peter HodsonWell run. Expect they may be currently trying to raise money.2003-02-04
TOP PICK1.430Brendan KyneNew TSX listing. Good sales. Good contracts.2002-08-26

Privacy Policy



Other worthy sites:

Powered by phpMyEdit of Platon Group
Life Insurance Canada - Canadian life insurance broker with online life insurance shopping.
American Universal Life Insurance
American term life insurance quotes
Canadian term life insurance rates
Our Main Page

www.financialwebring.com